Recursion Pharmaceuticals Inc - Class A (RXRX) gains 3.09% for July 21

Equities Staff  |

Recursion Pharmaceuticals Inc - Class A (NASDAQ: RXRX) shares gained 3.09%, or $1.08 per share, to close Wednesday at $35.99. After opening the day at $34.78, shares of Recursion fluctuated between $36.88 and $34.00. 216,683 shares traded hands a decrease from their 30 day average of 506,695. Wednesday's activity brought Recursion’s market cap to $6,057,863,613.

About Recursion Pharmaceuticals Inc - Class A

Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to its mission is the Recursion Operating System, or Recursion OS, that combines an advanced infrastructure layer to generate what Recursion believes is one of the world's largest and fastest-growing proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that the company uses to explore foundational biology unconstrained by human bias and navigate to new biological insights which may accelerate its programs. biotechnology company scaling more like a technology company.

Visit Recursion Pharmaceuticals Inc - Class A’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on Recursion Pharmaceuticals Inc - Class A and to follow the company’s latest updates, you can visit the company’s profile page here: Recursion Pharmaceuticals Inc - Class A’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Market Movers

Sponsored Financial Content